hIFNGR1/hIFNGR2
品系全名
C57BL/6JSmo-Ifngr1tm3(hIFNGR1)Ifngr2tm(hIFNGR2)Smoc
目录号
NM-HU-220003
品系状态
活体
品系描述
验证数据
Fig1. Detection of IFNGR1 expression in colon by RT-PCR.
Wild type: only one band at 405 bp with primers F1/R1(mIfngr1);
Homozygous: only one band at 461 bp with primers F2/R2(hIFNGR1);
Abbr. M, DNA marker; HO, homozygous; WT, wild type.
Fig2. Detection of IFNGR2 expression in small intestine by RT-PCR.
Wild type: only one band at 286 bp with primers F1/R1(mIfngr2);
Homozygous: only one band at 418 bp with primers F2/R2(hIFNGR2);
Abbr. M, DNA marker; HO, homozygous; WT, wild type.
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
